Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
UBS
Medtronic
Citi
Teva
Covington
Merck
Boehringer Ingelheim
Healthtrust
Johnson and Johnson

Generated: August 23, 2017

DrugPatentWatch Database Preview

ULTRAVATE Drug Profile

« Back to Dashboard

What is the patent landscape for Ultravate, and what generic Ultravate alternatives are available?

Ultravate is a drug marketed by Sun Pharm Inds Ltd, Ranbaxy, and Sun Pharm Inds. and is included in three NDAs. There is one patent protecting this drug.

This drug has fourteen patent family members in fourteen countries.

The generic ingredient in ULTRAVATE is halobetasol propionate. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.

Summary for Tradename: ULTRAVATE

Patents:1
Applicants:3
NDAs:3
Suppliers / Packagers: see list2
Bulk Api Vendors: see list13
Clinical Trials: see list8
Patent Applications: see list2,061
Drug Prices:see details
DailyMed Link:ULTRAVATE at DailyMed

Pharmacology for Tradename: ULTRAVATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
ULTRAVATE
halobetasol propionate
CREAM;TOPICAL019967-001Dec 27, 1990ABRXYesNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
ULTRAVATE
halobetasol propionate
LOTION;TOPICAL208183-001Nov 6, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Ranbaxy
ULTRAVATE
halobetasol propionate
OINTMENT;TOPICAL019968-001Dec 17, 1990ABRXYesNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
ULTRAVATE
halobetasol propionate
LOTION;TOPICAL208183-001Nov 6, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ULTRAVATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Ltd
ULTRAVATE
halobetasol propionate
CREAM;TOPICAL019967-001Dec 27, 1990► Subscribe► Subscribe
Ranbaxy
ULTRAVATE
halobetasol propionate
OINTMENT;TOPICAL019968-001Dec 17, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ULTRAVATE

Country Document Number Estimated Expiration
Japan2015534980► Subscribe
Australia2013331271► Subscribe
Canada2888853► Subscribe
Mexico2015004863► Subscribe
India4160DEN2015► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Julphar
Dow
Queensland Health
Teva
Boehringer Ingelheim
Chubb
Citi
Healthtrust
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot